Results 141 to 150 of about 25,074 (200)

Deep learning differentiates myeloproliferative neoplasms and predicts JAK2 and CALR mutations from bone marrow smears. [PDF]

Ann Hematol
Eckardt JN, Reddy CBV, Hauspurg H, Riechert S, Schmittmann T, Srivastava I, Winter S, Sockel K, Badstübner M, Bornhäuser M, Tiemann M, Middeke JM.   +11 more
europepmc   +1 more source

Underlying thrombotic conditions in patients with splenic infarction: a 10-year retrospective analysis. [PDF]

Thromb J
Karabulut U, Ebik B, Yolacan R, Ugur Y, Oncul FY, Kaya M.   +5 more
europepmc   +1 more source

Obstetric and thrombotic outcomes among pregnant patients with myeloproliferative neoplasms: a propensity score matched real-world analysis. [PDF]

Ann Hematol
Vojjala N, Srungavarapu SR, Nanjareddy S, Kannan MV, Prabhu R, Arsene C, Krishnamoorthy G, Singh V.   +7 more
europepmc   +1 more source

Budd-Chiari Syndrome Manifesting in Pregnancy: Case Report and Review of Management and Outcomes. [PDF]

Reports (MDPI)
Foster HS, Kirschen GW, Bechard S, Gerson KD.   +3 more
europepmc   +1 more source

Clinical and Laboratory Characterization of Acquired Von Willebrand Syndrome. [PDF]

Am J Hematol
Ciavarella A, Baronciani L, Seidizadeh O, Colpani P, Ingenito E, Cattaneo D, Pagliari MT, Truma A, Iurlo A, Siboni SM, Peyvandi F.   +10 more
europepmc   +1 more source

The Current Landscape of Pulmonary Hypertension in Myeloproliferative Neoplasms. [PDF]

Cancers (Basel)
Ferrante M, Ali HJ, Hobbs G, Leiva O.
europepmc   +1 more source

Does disease ontogeny matter more than JAK2 mutation status in acute myeloid leukemia? [PDF]

Cancer
Babu NS, Sangeetha KSS.
europepmc   +1 more source

A comprehensive analysis of the incidence of chromosomal abnormalities in hematologic malignancies post-COVID-19 outbreak in King Chulalongkorn Memorial Hospital, Thailand. [PDF]

Asian Biomed (Res Rev News)
Tansatit M, Jongpornchai N, Songchart S, Krajokpap K, Da-Oh H.   +4 more
europepmc   +1 more source